CALCIUM CHANNEL BLOCKERS AS A ETHIOLOGICAL FACTOR FOR GASTROESOPHAGEAL REFLUX DISEASE

Аннотация

Gastroesophageal reflux disease is the most common visceral manifestation of chronic calcium channel blockers use, resulting in impaired esophageal clearance and retention of ingested food. Progression of gastroesophageal reflux disease and the damaging effect of due to esophageal dysmotility is clearly understood . Nifedipine is a widely prescribed calcium antagonist in a significant percentage of ischaemic heart disease patients in order to inhibit coronal vasospasm. We describe the case of severe exacerbation of gastroesophageal reflux disease in a 76-year-old female with Gastroesophageal refluxe disease who was treated with oral nifedipine for Ischaemic heart disease.